Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure

Citation
Xl. Mu et al., Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure, ANN NUCL M, 15(5), 2001, pp. 411-416
Citations number
30
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
ANNALS OF NUCLEAR MEDICINE
ISSN journal
09147187 → ACNP
Volume
15
Issue
5
Year of publication
2001
Pages
411 - 416
Database
ISI
SICI code
0914-7187(200110)15:5<411:CVOLUO>2.0.ZU;2-L
Abstract
This study investigated the clinical value of I-123 MIBG pulmonary accumula tion and washout in patients with chronic heart failure (CHF). Nineteen pat ients with CHF and 15 normal volunteers (NL) were included. The uptake rati o of heart to mediastinum (H/M), that of lung fields to mediastinum (L/M), and washout rate (WR) of the heart and lung fields were calculated in anter ior planar images and compared with results of echocardiography and cardiac catheterization. In the CHF group, the lung uptake in delayed images incre ased and lung WR was decreased, suggesting pulmonary endothelial lesions. F urthermore, there was a negative correlation between right and left lung WR and pulmonary arterial diastolic pressure (PA(D)) and pulmonary arterial s ystolic pressure (PA(S)) in the CHF group. Since the WR of MIBG reflected P A, it may be used as an index of severity of cardiac dysfunction.